Advanced Cancer Refractory
1 clinical trials · Condition
◉ Watch Advanced Cancer Refractory
| Record | Firm | Date |
|---|---|---|
| A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED) (NCT00632931) | Merck Sharp & Dohme LLC | 2007-07-01 |
Track Advanced Cancer Refractory automatically
Every clearance here is in the API, with alerts when new ones post.